LeonaBio (LONA) Assets Average (2020 - 2026)
LeonaBio (LONA) posted quarterly Assets Average of $81.9 million for Q1 2026, up 60.07% year-over-year from $51.1 million in Q1 2025, and up 34.01% quarter-over-quarter from $61.1 million in Q4 2025.
LeonaBio (LONA) Assets Average (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Assets Average for 7 consecutive years, with $81.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 60.07% year-over-year to $81.9 million; the TTM figure through Mar 2026 stood at $81.9 million (up 60.07% YoY), while the FY2025 annual figure was $75.5 million, down 31.09% from the prior year.
- Assets Average improved to $81.9 million in Q1 2026 per LONA's latest filing, from $61.1 million in the prior quarter.
- Across five years, Assets Average topped out at $322.5 million in Q1 2022 and bottomed at $32.8 million in Q3 2025.
- Historically, Assets Average has averaged $159.8 million across 5 years, with a median of $146.9 million in 2024.
- Annual changes were most pronounced in 2025 — Assets Average slumped 67.69% — and 2026, when it jumped 60.07%.
- LeonaBio's Assets Average stood at $266.2 million in 2022, then slumped by 35.2% to $172.5 million in 2023, then plunged by 57.96% to $72.5 million in 2024, then fell by 15.75% to $61.1 million in 2025, then surged by 34.01% to $81.9 million in 2026.
- Business Quant data shows LONA's Assets Average at $81.9 million in Q1 2026, $61.1 million in Q4 2025, and $32.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | LeonaBio | 182.69 Mn | 131.62 Mn | - | 64.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.87 Mn |
| Dec 31, 2025 | 61.09 Mn |
| Sep 30, 2025 | 32.79 Mn |
| Jun 30, 2025 | 39.53 Mn |
| Mar 31, 2025 | 51.15 Mn |
| Dec 31, 2024 | 72.51 Mn |
| Sep 30, 2024 | 98.75 Mn |
| Jun 30, 2024 | 122.36 Mn |
| Mar 31, 2024 | 146.85 Mn |
| Dec 31, 2023 | 172.47 Mn |
| Sep 30, 2023 | 196.37 Mn |
| Jun 30, 2023 | 220.41 Mn |
| Mar 31, 2023 | 245.46 Mn |
| Dec 31, 2022 | 266.17 Mn |
| Sep 30, 2022 | 283.10 Mn |
| Jun 30, 2022 | 302.51 Mn |
| Mar 31, 2022 | 322.51 Mn |
| Dec 31, 2021 | 339.67 Mn |
| Sep 30, 2021 | 353.73 Mn |
| Jun 30, 2021 | 364.77 Mn |